Blood-brain barrier impairment in an animal model of MPS III B

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Garbuzova Davis, Svitlana ^a   Louis, Michael K ^a   Haller, Edward M ^b   Derasari, Hiranya M ^a   Rawls, Ashley E ^a   Sanberg, Paul R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; EVANS BLUE; GANGLIOSIDE GM3; ACETYLGLUCOSAMINIDASE; ALBUMINOID; ALPHA N ACETYL D GLUCOSAMINIDASE; ALPHA-N-ACETYL-D-GLUCOSAMINIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CELL ULTRASTRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; LIPID STORAGE; MALE; MEMBRANE DAMAGE; MICROANEURYSM; MICROVASCULATURE; MOUSE; NEUROANATOMY; NEUROPATHOLOGY; NONHUMAN; SANFILIPPO SYNDROME; SANFILIPPO SYNDROME TYPE B; STRUCTURE ANALYSIS; ANIMAL; DISEASE MODEL; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE MUTANT; PATHOLOGY; ULTRASTRUCTURE;

ANIMALIA; MUS;

ACETYLGLUCOSAMINIDASE; ALBUMINS; ANIMALS; BLOOD-BRAIN BARRIER; DISEASE MODELS, ANIMAL; EVANS BLUE; G(M3) GANGLIOSIDE; IMMUNOHISTOCHEMISTRY; MICE; MICE, MUTANT STRAINS; MICROVESSELS; MUCOPOLYSACCHARIDOSIS III;

EID: 79952355760     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016601     Document Type: Article

References (30)

1. Weber B, Guo XH, Kleijer WJ, van de Kamp JJ, Poorthuis BJ, et al. (1996) Sanfilippo type B syndrome (mucopolysaccharidosis type III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes. Eur J Hum Genet 7: 34-44.
2. Beesley C, Young EP, Vellodi A, Winchester BG, (1998) Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB). J Med Genet 35: 910-914.
3. Barone R, Nigro F, Triulzi F, Musumeci S, Fiumara A, et al. (1999) Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome). Neuropediatrics 30: 270-274.
4. Zafeiriou DI, Savvopoulou-Augoustidou PA, Sewell A, Papadopoulou F, Badouraki M, et al. (2001) Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B). Brain Dev 23: 385-389.
5. Ferrer I, Cusí V, Pineda M, Galofré E, Vila J, (1988) Focal dendritic swellings in Purkinje cells in mucopolysaccharidoses types I, II and III. A Golgi and ultrastructural study. Neuropathol Appl Neurobiol 14: 315-323.
6. Neufeld EF, Muenzer J, (2001) The mucopolysaccharidoses. McGraw-Hill In: The Metabolic and Molecular Bases of Inherited Disease pp. 3421-3452.
7. Li HH, Yu WH, Rozengurt N, Rozengurt N, Zhao HZ, et al. (1999) Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding α-N-acetylglucosaminidase. Proc Natl Acad Sci USA 96: 14505-14510.
8. Heldermon CD, Hennig AK, Ohlemiller KK, Ogilvie JM, Herzog ED, et al. (2007) Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B. PLoS ONE 2 Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000772. Accessed 19 December 2007.
9. Walkley SU, (2004) Secondary accumulation of gangliosides in lysosomal storage disorders. Semin Cell Dev Biol 15: 433-444.
10. McGlynn R, Dobrenis K, Walkley SU, (2004) Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 480: 415-426.
11. Li HH, Zhao HZ, Neufield EF, Cai Y, Gomez-Pinilla F, (2003) Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo Syndrome type B. J Neurosci Res 69: 30-38.
12. Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, et al. (2003) Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 100: 1902-1907.
13. Pardridge WM, (1999) Blood-brain barrier biology and methodology. J NeuroVirol 5: 556-569.
14. Vorbrodt AW, Dobrogowska DH, (2003) Molecular anatomy of intercellular junctions in the brain endothelial and epithelial barriers: electron microscopist's view. Brain Res Rev 42: 221-242.
15. Ballabh P, Braun A, Nedergaard M, (2004) The blood-brain barrier: an overview structure, regulation, and clinical implications. Neurobiol Dis 16: 1-13.
16. Begley DJ, Pontikis CC, Scarpa M, (2008) Lysosomal storage diseases and the blood-brain barrier. Cur Pharmac Design 14: 1566-1580.
17. Jeyakumar M, Thomas R, Elliot-Smith E, Smith DA, van der Spoel AC, et al. (2003) Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 126: 974-987.
18. Hamano K, Hayashi M, Shioda K, Fukatsu R, Mizutani S, (2008) Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue. Acta Neuropath 115: 547-559.
19. Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennet SP, et al. (2007) Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One 2 Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001205. Accessed 23 November 2007.
20. Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, et al. (2007) Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res 1157: 126-137.
21. Begley DJ, Bringhtman MW, (2003) Structural and functional aspects of the blood-brain barrier. Prog Drug Res 61: 39-78.
22. Begley DJ, (2004) ABC transporters and the blood-brain barrier. Curr Pharm Res 10: 1295-1312.
23. Guillemin GJ, Brew BJ, (2004) Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and differentiation. J Leukoc Biol 75: 388-397.
24. Hirschi KK, D'Amore PA, (1996) Pericytes in the microvasculature. Cardiovasc Res 32: 687-698.
25. Díaz-Flores L, Gutiérrez R, Madrid JF, Varela H, Valladares F, et al. (2009) Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 24: 909-969.
26. Kutcher ME, Herman IM, (2009) The pericyte: cellular regulator of microvascular blood frow. Microvascular Res 77: 235-246.
27. D'Amore PA, (1992) Mechanisms of endothelial growth control. Am J Respir Cell Mol Biol 6: 1-8.
28. Sasaki A, Nakazato Y, Ogawa A, Sugihara S, (1996) The immunophenotype of perivascular cells in the human brain. Pathol Int 46: 15-23.
29. Kida S, Steart PV, Zhang ET, Weller RO, (1993) Perivascular cells act as scavengers in the cerebral perivascular spaces and remain distinct from pericytes, microglia and macrophages. Acta Neuropathol 85: 646-652.
30. Polfliet MM, Zwijnenburg PJG, van Furth AM, van der Poll T, Döpp EA, et al. (2001) Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis. J Immunol 167: 4644-4650.